OpenAI and Anthropic Target Health Care for AI Expansion

Jan 9, 2026, 2:45 AM
Image for article OpenAI and Anthropic Target Health Care for AI Expansion

Hover over text to view sources

OpenAI and Anthropic are increasingly eyeing the health care sector as a significant market for artificial intelligence (AI) applications. Both companies are not looking to develop new health-focused apps but rather to integrate health data into their existing platforms, such as ChatGPT and Claude, respectively.
The strategic advantage for these tech giants lies in their already established user bases. OpenAI's ChatGPT and Anthropic's Claude have millions of daily active users, making it easier to distribute health-related features without the need for a separate application. This approach allows them to embed health data into tools that users are already familiar with, thereby enhancing user engagement and utility.
The recent pledge by the Centers for Medicare & Medicaid Services (CMS) emphasizes the need for conversational AI assistants that can securely access health information with patient consent. This aligns with OpenAI and Anthropic's capabilities, as they can leverage their existing technologies to meet these requirements. The integration of health data into their platforms could facilitate personalized health support, guiding users to appropriate care when necessary.
Historically, consumer technology companies have struggled to penetrate the health care market due to the complexities involved in accessing and managing health data. However, advancements in health care infrastructure, particularly through initiatives like the CMS pledge, are making it easier for companies to connect with health data sources. If these infrastructures become more ubiquitous, the challenge will shift from accessing health data to effectively utilizing it within consumer applications.
The potential for AI in health care is vast. According to McKinsey, the long-term opportunity for AI in corporate use cases, including health care, is estimated at $4.4 trillion in added productivity growth. This figure underscores the transformative potential of AI technologies in improving health outcomes and operational efficiencies within the sector.
Moreover, the demand for AI applications in health care is growing rapidly. In 2025, the market for AI applications is projected to reach $19 billion, with a significant portion allocated to verticals like health care. This growth reflects a broader trend where enterprises are prioritizing immediate productivity gains through AI, rather than long-term infrastructure investments.
As AI technologies continue to evolve, the capabilities of large language models (LLMs) are also advancing. Recent developments have shown that these models can now perform complex reasoning and decision-making tasks, which are crucial for applications in health care. For instance, OpenAI's models have demonstrated the ability to pass medical licensing examinations, indicating their potential to assist in clinical decision-making.
The integration of AI into health care is not without challenges. Companies must navigate regulatory landscapes and ensure that their technologies comply with health care standards. Additionally, there is a need for robust data privacy measures to protect patient information as these technologies are deployed.
In conclusion, OpenAI and Anthropic are strategically positioning themselves to capitalize on the health care market by embedding AI capabilities into their existing platforms. This approach not only leverages their established user bases but also aligns with the evolving health care infrastructure that is becoming more conducive to AI integration. As the demand for AI in health care continues to grow, these companies are well-placed to lead the charge in transforming how health care is delivered and experienced.

Related articles

Insilico Medicine's IPO Fuels AI-Driven Drug Discovery Success

Insilico Medicine has made headlines by successfully launching its IPO in Hong Kong, raising approximately $293 million. The company has quickly advanced its AI-driven drug candidate, rentosertib, into phase 2 trials for idiopathic pulmonary fibrosis, showcasing the potential of AI in accelerating drug discovery.

Concerns Rise Over OpenAI's ChatGPT Health and Patient Safety

As OpenAI's ChatGPT Health gains traction in the medical field, some doctors express concerns about its potential to harm patients. Issues such as inaccuracies, data privacy, and the risk of over-reliance on AI tools are at the forefront of discussions among healthcare professionals.

OpenAI Launches ChatGPT Health for Medical Record Analysis

OpenAI has introduced ChatGPT Health, a feature designed to analyze users' medical records and wellness data to provide personalized health insights. While the tool aims to enhance user understanding of health-related questions, privacy advocates express concerns over data security and the potential misuse of sensitive information.

OpenAI Launches ChatGPT Health for Personalized Medical Insights

OpenAI has introduced ChatGPT Health, a new feature allowing users to connect their medical records and wellness apps to the AI chatbot. This initiative aims to provide personalized health information while ensuring user data remains secure and separate from other interactions.

40 Million Users Turn to ChatGPT Daily for Health Questions

OpenAI reports that over 40 million users engage with ChatGPT daily for healthcare inquiries. The chatbot serves as a vital resource, especially during off-hours, helping users navigate the complexities of health insurance and medical information.